Malin Corporation | MLC - Ordinary Share Capital

Stock Price
7.45
Daily Change
-0.15 -1.97%
Monthly
-6.88%
Yearly
-12.35%
Q2 Forecast
7.23

Malin Corporation reported EUR200K in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
ALKERMES USD 166.46M 855K Mar/2026
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Eurofins Scientific SE EUR 177.9M 0 Dec/2025
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organon & Co USD 260.32M 333K Dec/2025
Ovoca Bio EUR 29.49M 18.43M Jun/2025
Revvity USD 111.8M 1.57M Mar/2026
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025